Inhibition of hepatic UGT1A1 and UGT1A6 by the milk thistle constituent silibin in primary cultures of human hepatocytes

被引：0
|
作者：
Komoroski, BJ
Cai, HB
Chandler, J
Graber, AY
Innocenti, F
Ramirez, J
Strom, SC
Venkataraman, R
机构：
[1] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA
[3] Univ Chicago, Dept Med, Chicago, IL 60637 USA
来源：
DRUG METABOLISM REVIEWS | 2003年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
112
引用
收藏
页码：56 / 56
页数：1
相关论文
共 50 条
  • [1] The Development of UGT1A1 and UGT1A6 in Pediatric Liver
    Miyagi, Shogo J.
    Abby, C.
    DRUG METABOLISM REVIEWS, 2009, 41 : 17 - 18
  • [2] Linkage disequilibrium of UGT1A1*6 and UGT1A1*28 in relation to UGT1A6 and UGT1A7 polymorphisms
    Urawa, Naohito
    Kobayashi, Yoshinao
    Araki, Jun
    Sugimoto, Ryosuke
    Iwasa, Motoh
    Kaito, Masahiko
    Adachi, Yukihko
    ONCOLOGY REPORTS, 2006, 16 (04) : 801 - 806
  • [3] Interactions between human UGT1A1, UGT1A4, and UGT1A6 affect their enzymatic activities
    Fujiwara, Ryoichi
    Nakajima, Miki
    Yamanaka, Hiroyuki
    Katoh, Miki
    Yokoi, Tsuyoshi
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (10) : 1781 - 1787
  • [4] CHARACTERIZATION OF CYNOMOLGUS MONKEY UGT1A6: COMPARISON WITH HUMAN UGT1A6
    Hanioka, Nobumitsu
    Takeda, Yuri
    Jinno, Hideto
    Tanaka-Kagawa, Toshiko
    Naito, Shinsaku
    Shimizu, Takefumi
    Narimatsu, Shizuo
    DRUG METABOLISM REVIEWS, 2007, 39 : 187 - 188
  • [5] THE POLYMORPHISMS OF UGT1A1 AND UGT1A6 INFLUENCE ACETAMINOPHEN METABOLISM AND BILIRUBIN IN VIVO
    Guo, Dong
    Zhou, Honghao
    DRUG METABOLISM REVIEWS, 2008, 40 : 156 - 156
  • [6] Non tumoral hyperserotoninaemia responsive to octreotide due to dual polymorphism in UGT1A1 and UGT1A6
    Maladaki, Anna
    Yavropoulou, Maria P.
    Kotsa, Kalliopi
    Tranga, Theoni
    Ventis, Stelios
    Yovos, John G.
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2012, 11 (01): : 104 - 108
  • [7] Non tumoral hyperserotoninaemia responsive to octreotide due to dual polymorphism in UGT1A1 and UGT1A6
    Anna Maladaki
    Maria P. Yavropoulou
    Kalliopi Kotsa
    Theoni Tranga
    Stelios Ventis
    John G. Yovos
    Hormones, 2012, 11 : 104 - 108
  • [8] Inhibition of UGT1A1*1 and UGT1A1*6 catalyzed glucuronidation of SN-38 by silybins
    Li, Wei
    Chen, Yin-Nan
    Chen, Yue-Yue
    Wang, Zhe
    Wang, Zhen
    Jiang, Li-Li
    Shi, Hong-Can
    Liu, Yong
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 368
  • [9] UGT1A1*6 and UGT1A1*27 for individualized irinotecan chemotherapy
    Ando, Yuichi
    Fujita, Ken-ichi
    Sasaki, Yasutsuna
    Hasegawa, Yoshinori
    CURRENT OPINION IN MOLECULAR THERAPEUTICS, 2007, 9 (03) : 258 - 262
  • [10] TCDD-inducible UDP-glucuronosyltranferases (UGT1A6 and UGT1A6) in human cells
    Lehmköster, T
    Heel, H
    Münzel, P
    Bock, KW
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 357 (04) : R134 - R134
12345